miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 601–700 of 767
Ortiz-Melo, M. T., Campos, J. E., Sánchez‐Guzmán, E., Herrera-Aguirre, M. E., & Castro‐Muñozledo, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315296 · Cited by 4
Generating Pancreatic Endocrine Cells from Pluripotent Stem Cells
Gage, B. K., Wideman, R. D., & Kieffer, T. J. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_49-2 · Cited by 5
Ofori, J. K., Malm, H. A., Mollet, I. G., Eliasson, L., & Esguerra, J. L. S. (2017) · PeerJ · doi:10.7717/peerj.3503 · Cited by 4
Zhao, F., Liu, X., Wang, Z., Lang, H., Zhang, T., Wang, R., Lin, X., He, D., Shi, P., & Pang, X. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.001 · Cited by 4
Chen, W., Jiang, W., Dong, J., Wang, J., & Wang, B. (2022) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2022041822 · Cited by 4
Madhoun, A. S. A., Haddad, D., Nizam, R., Miranda, L., Kochumon, S., Thomas, R., Thanaraj, T. A., Ahmad, R., Bitar, M. S., & Al‐Mulla, F. (2022) · Cells · doi:10.3390/cells11233937 · Cited by 4
“MiR-124a has been shown to activate CAV1 in podocytes [8], miR-375 to downregulate CAV1 gene expression, and miR-204 to target CAV1 mRNA and decrease its expression in endothelial cells [9].”
BackgroundMohammadi, S. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000158 · Cited by 5
Tian, Z., Yang, Y., Feng, Z., Wu, D., Yang, W., & Liu, D. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10205 · Cited by 4
Athira, S. V., Misra, P., Bhatia, K., & Sibin, M. K. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100954 · Cited by 4
Epigenetic-Mediated Reprogramming of Pancreatic Endocrine Cells
Mathiyalagan, P., Keating, S. T., Al‐Hasani, K., & El‐Osta, A. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6103 · Cited by 3
Carr, E. R., Higgins, P. B., McClenaghan, N. H., Flatt, P. R., & McCloskey, A. G. (2024) · Peptides · doi:10.1016/j.peptides.2024.171196 · Cited by 4
“Poy et al. also signified the importance of this miRNA in insulin secretion through miR-375 ablation in leptin-deficient mice, with resultant impairments towards beta-cell mass and plasma insulin in response to insulin resistance (IR) [82].”
BackgroundResultPalihaderu, P. A. D. S., Mendis, B. I. L. M., Premarathne, J. M. K. J. K., Dias, W. K. R. R., Yeap, S. K., Ho, W. Y., Dissanayake, A. S., Rajapakse, I. H., Karunanayake, P., Senarath, U., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1554827 · Cited by 3
The miR-200 family in type 2 diabetes: therapeutic and biomarker perspectives
Ajonijebu, T. E., & Mazibuko-Mbeje, S. E. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109211 · Cited by 3
Zhu, B. J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1753393 · Cited by 3
“…cells, contributing to fi brogenesis (70). miR-143 inhibition protects against insulin resistance (71), while elevated miR-143 may serve as a diagnostic biomarker for MASH (72). miR-375 is essential for maintaining normal pancreatic alpha-and beta-cell mass and thus normal glucose homeostasis (73).”
Polyphenols and flavonoids in the prevention and treatment of diabetes type 2
Wałkuski, M., Szwed, O., Lendzioszek, M., & Terlikowska, K. M. (2018) · Progress in Health Sciences · doi:10.5604/01.3001.0012.8343 · Cited by 5
“In this respect, mice show increased expression of miRNA 375, and for those that have low miRNA 375 expression, low insulin synthesis and hyperglycaemia are observed [7].”
BackgroundKhare, S., Jiang, L., Paine‐Cabrera, D., Apte, U. M., & Pritchard, M. T. (2023) · Livers · doi:10.3390/livers3030025 · Cited by 3
miRNA-642a-3p protects β cells from glucolipotoxicity
Pinhanços, S. S., Oliveira, J. M., Alves, C. H., Deus, C. M., de Winter, T. J. J., Viana, S., Reis, F., Santos, J., Buitinga, M., Carlotti, F., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102498 · Cited by 3
Ito, K., Ookawara, S., Ishibashi, K., & Morishita, Y. (2017) · Nano Reviews & Experiments · doi:10.1080/20022727.2017.1341758 · Cited by 3
RNA-Binding Protein HuD Controls Insulin Translation
Lee, E. K., Kim, W., Tominaga, K., Martindale, J. L., Yang, X., Subaran, S. S., Carlson, O. D., Mercken, E. M., Kulkarni, R., Akamatsu, W., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.039 · Cited by 3
Physiological and Pathological Roles for MicroRNAs: Implications for Immunity Complications
Firoozabadi, A. D., Shojaeii, S., & Hadinedoushan, H. (2014) · Cited by 5
Bhaumik, S., Ahmad, F., & Das, B. R. (2017) · Applied cancer research/Applied Cancer Research · doi:10.1186/s41241-017-0034-8 · Cited by 3
“Discussion Initially, miR-375 was discovered as a key player in glucose metabolism and insulin secretion [12, 13], and was later found to be associated with tumorigenesis and deregulated in several types of cancer.”
BackgroundHung, Y.-H., Capeling, M. M., Villanueva, J., Kanke, M., Shanahan, M. T., Huang, S., Cubitt, R. L., Rinaldi, V. D., Schimenti, J. C., Spence, J. R., et al. (2023) · BMC Genomics · doi:10.1186/s12864-023-09743-1 · Cited by 3
Roles of Micro-RNAs in Metabolism
Wei, Z., & Wong, G. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00078-5 · Cited by 3
Circadian regulation of microRNA-target chimeras in DrosophilaPreprint
Xia, X., Fu, X., Wu, B., Zhu, J., & Zhao, Z. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/622183 · Cited by 3
Zhao, X., Ding, C., Zhang, H. Z., Xu, Y., Gong, Y., Hao, D., Wang, Z., & Li, X. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.108827 · Cited by 2
Chen, P., Cheng, M., Wang, J., Tang, J. Y., Huang, X., Li, Y., Zhou, H., Zhang, L., Dong, Y., Li, C., et al. (2026) · Advanced Science · doi:10.1002/advs.202513486 · Cited by 2
microRNAs in Drug‐Induced Liver Toxicity
Chenand, S., Xuan, J., & Guo, L. (2013) · Wiley eBooks · doi:10.1002/9781118695999.ch3 · Cited by 2
MicroRNAs—Basic Biology and Therapeutic Potential
Loomis, A. K., & Brock, G. (2011) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-386009-5.00006-0 · Cited by 4
The roles of micro RNA in pancreas development and regeneration
Rabe, T., Shamsi, F., & Mansouri, A. (2013) · Biomedical Reviews · doi:10.14748/bmr.v24.22 · Cited by 2
Farr, R. J., Taylor, C. J., Satoor, S. N., Williams, M. D., & Joglekar, M. V. (2013) · Non-coding RNAs in Endocrinology · doi:10.2478/micrnado-2013-0004 · Cited by 4
STEM CELL THERAPY IN DIABETES MELLITUS: CURRENT TRENDS
Sarath, R., & Rani, V. L. (2012) · International Journal of Biomedical Research · doi:10.7439/ijbr.v2i12.239 · Cited by 2
MicroRNAs: Decoders of Dysbiosis into Metabolic Diseases?
Sérino, M. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000698 · Cited by 2
Noncoding RNAs in metabolism and metabolic disease
Fu, X. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00060 · Cited by 2
Zhang, X., Shao, S., Zhao, X., Zhang, M., & Wang, J. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101273 · Cited by 2
“miR-375, a highly expressed miRNA in islets, is essential for normal glucose homeostasis [23].”
BackgroundAntidiabetic agents: Do they hit the right targets?
Zhao, Y., Zhang, X., Liang, H., & Wang, L. (2022) · Frigid Zone Medicine · doi:10.2478/fzm-2022-0030 · Cited by 2
The role of noncoding RNAs in pancreatic birth defects
Yang, Z., & Parchem, R. J. (2023) · Birth Defects Research · doi:10.1002/bdr2.2178 · Cited by 2
“Knocking down miR-375 in zebrafish embryos leads to morphological changes in islets such as endocrine cells not being clustered, but found in a scattered distribution (Kloosterman et al., 2007).”
BackgroundInfluentialElsayed, A. K., Aldous, N., Alajez, N. M., & Abdelalim, E. M. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10752-0 · Cited by 2
“Our integration analysis revealed several dysregulated”
Transgenic and other experimental models of pancreas and islet damage
Herrera, P. L. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01104.x · Cited by 2
MicroRNAs and pancreatic-endocrine system
Luzi, E., D’Asta, F., & Brandi, M. L. (2013) · Non-coding RNAs in Endocrinology · doi:10.2478/micrnado-2013-0003 · Cited by 2
MicroRNAs in Cardiometabolic Diseases
Meiliana, A., & Wijaya, A. (2013) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v5i2.55 · Cited by 3
MicroRNAs: A Link Between Type 1 Diabetes and the Environment?
Akil, A. A., Ho, A., Figueroa, C., Rawlinson, W. D., & Craig, M. E. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-45307-1_7 · Cited by 2
Farmer, L. M., & Hirschi, K. D. (2017) · Wiley eBooks · doi:10.1002/9781119101277.ch9 · Cited by 2
miR-375 is downregulated by promoter hypermethylation in MIN6 insulinoma cells.
Wei, Y., Cai, W., Kuang, X., & Yin, L. (2018) · Europe PMC (PubMed Central) · Cited by 2
Online learners take the lead in self-direction
Boyer, N. R. (2005) · Academic exchange quarterly · Cited by 3
Zhao, Q., Su, S., Lin, Y., Li, X., Dan, L., Yang, C., Geng, C., Regazzi, R., Li, X., Dong, Y., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2808181 · Cited by 2
Exosomal RNA in type 2 diabetes mellitus and other metabolic diseases
Ghoshal, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14008-2.00009-7 · Cited by 3
Mziaut, H., Henniger, G., Ganß, K., Hempel, S., Wolk, S., McChord, J., Chowdhury, K., Knoch, K.-P., Weitz, J., Pilarsky, C. P., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/233098 · Cited by 3
“Similarly, its global inactivation in mice resulted in decreased beta cell mass and ultimately diabetes (Poy et al., 2009; Latreille et al., 2015).”
BackgroundResultInfluential(2019) · BioFactors · doi:10.1002/biof.1588 · Cited by 2
RetractedRole of microRNAs and their machinery in hepatocytes and pancreatic beta cells
Fabris, G. (2019) · theses.fr (ABES) · doi:10.70675/8a056402z7559z4215z937ez61cad022a58e · Cited by 3
Therapeutic Potential of Mesenchymal Stem Cells and miRNAs in Diabetes
Jafarian, A., & Soleimani, M. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-55687-1_5 · Cited by 1
MicroRNAs in Type 2 Diabetes: Focus on MicroRNA Profiling in Islets of Langerhans
Cowan, E., Karagiannopoulos, A., & Eliasson, L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2807-2_8 · Cited by 1
Type 1 Diabetes in 2023 - From Real Practice to Open Questions
Chlup, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100991 · Cited by 1
Crosstalk between microRNA and inflammation; critical regulator of diabetes
El‐Sehrawy, A. A. M. A., Mohammed, M. H., Salahdin, O. D., Uthirapathy, S., Ballal, S., Kalia, R., Arya, R., Joshi, K. K., Kadim, A. S., & KADHIM, A. J. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114507 · Cited by 2
Sassi, A., Bakhtiar, M., Khattak, M. M. A. K., Haron, N., Kaderi, M. A., Rostam, M. A., & Jusoh, H. M. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70077 · Cited by 1
Yu, J., Xia, K., Feng, J., Xu, Z., Zhang, Z., Xiao, G., Zhu, H., Xue, W., Chen, F., & Xie, X. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s533519 · Cited by 1
Meng, Z., Sewell-Loftin, M. K., Thomas, V., Ma, X., & Wang, Y. (2025) · Current Opinion in Physiology · doi:10.1016/j.cophys.2025.100862 · Cited by 1
Ying, Z., Liu, Z., Wan, Y., Ding, S., Liu, J., Wu, A., Dai, X., Zhou, J., Li, X., Gong, X., et al. (2025) · Aging Cell · doi:10.1111/acel.70326 · Cited by 1
“In addition to its role in cancer, other investigations have reported that miR- 375-3p serves as a biomarker for diabetes and plays essential roles in maintaining the normal function of pancreatic β-cells (Latreille et al. 2015; Poy et al. 2009).”
Regazzi, R. (2013) · Wiley eBooks · doi:10.1002/9781118300312.ch30 · Cited by 1
Modern Transcriptomics and Small RNA Diversity
Vickers, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-799961-6.00002-0 · Cited by 1
MicroRNAs in diabetes - are they perpetrators in disguise or just epiphenomena?
Puthanveetil, P., Thomas, A. A., & Chakrabarti, S. (2014) · Non-coding RNAs in Endocrinology · doi:10.2478/micrnado-2014-0002 · Cited by 2
Papagregoriou, G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3070-8_2 · Cited by 1
Role of Epigenetic Machinery and MicRNAs in Diet-Induced Hepatocarcinogenesis
Maulik, N., & Maulik, G. (2010) · CRC Press eBooks · doi:10.1201/b10449-12 · Cited by 1
Роль мікроРНК у розвитку цукрового діабету
Pischak, V. P., & Riznychuk, O. M. (2016) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.1.73.2016.71058 · Cited by 1
The Making of Pancreatic β Cells: Advances and Apprehensions
Radha, B., Muniraj, G., & Rasu, R. (2016) · International Journal of Pharmacology Phytochemistry and Ethnomedicine · doi:10.18052/www.scipress.com/ijppe.5.34 · Cited by 2
Role of Non-coding RNAs in Vascular Complications of Diabetes Mellitus
Surendran, S., & Kartha, C. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_15 · Cited by 1
Patil, K. S., & Møller, S. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_58 · Cited by 1
microRNAs in Nutritional Signaling and Metabolic Syndrome
Wade, H., & Su, Q. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22723-6 · Cited by 1
Liu, L., Lloyd, P. G., & Hinsdale, M. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405544-5.00015-0 · Cited by 1
Mukherjee, B., Chakraborty, S., Ehsan, I., Chakraborty, A., Kumari, L., Mukherjee, A., & Sarkhel, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-41858-8_6 · Cited by 1
Non-coding RNAS Related to Type 2 Diabetes
Holvoet, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-68844-8_3 · Cited by 1
In Vivo Biomarkers for Detection of Beta Cell Death
Hinke, S. A. (2013) · Springer eBooks · doi:10.1007/978-94-007-6884-0_35-1 · Cited by 1
Molecular Challenges and Advances in Clinical Islet Transplantation
Mohan, N., & Sunder, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108571 · Cited by 2
MicroRNA-224 Up-regulation: A Risk for Complications in Type 2 Diabetes Mellitus Egyptian Patients
Mohamed, A. A., Abo–Elmatty, D. M., Esmail, O. E., Salim, H. S. M., Salam, S. M. A. E., El-Ansary, A. R., Yacoub, M. F., Abdelrahman, S. A. I., Saleh, O. M., Hassan, Y. M., et al. (2022) · Pharmacophore · doi:10.51847/skwtzqgb22 · Cited by 1
Mohamed, A. A., Abo–Elmatty, D. M., Esmail, O. E., Salim, H. S. M., Salam, S. M. A. E., El-Ansary, A. R., Yacoub, M. F., Abdelrahman, S. A. I., Saleh, O. M., Hassan, Y. M., et al. (2022) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/ty4iyb1uia · Cited by 1
Leti, F., Taila, M., & DiStefano, J. K. (2014) · Springer eBooks · doi:10.1007/978-3-319-13689-9_11 · Cited by 1
Déviation de l’auto-immunité chez la souris NOD invalidée pour la voie ICOS/ICOSL
Briet, C. (2012) · theses.fr (ABES) · doi:10.70675/14d271c3z64dcz483dz86afz366c43a0eae6 · Cited by 1
Micro-managing the pancreatic β cell
Rathjen, T., Tattikota, S. G., & Poy, M. N. (2014) · Cell Cycle · doi:10.4161/cc.28513 · Cited by 1
Self-citationRibonucleoprotein Therapy in Alzheimer's Disease?
Yoon, J., & Gorospe, M. (2014) · Aging · doi:10.18632/aging.100672 · Cited by 1
The role of CADM1 in energy and glucose homeostasis
Matthäus, D. (2014) · doi:10.18452/16905 · Cited by 1
Bai, C., Li, X., Gao, Y., Lu, T., Wang, K., Li, Q., Xiong, H., Chen, J., Zhang, P., Wang, W., et al. (2014) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/003913 · Cited by 1
Pancreas-specific miR-216a regulates proliferation and endocrine and exocrine cell function in vivoPreprint
Erener, S., Ellis, C. E., Ramzy, A., Glavas, M. M., O’Dwyer, S. M., Pereira, S., Wang, T., Pang, J., Bruin, J. E., Riedel, M. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/792655 · Cited by 2
MicroRNAs in Obesity and Metabolism
Sousa-Ferreira, L., de Almeida, L. P., & Cavadas, C. (2014) · Springer eBooks · doi:10.1007/978-3-319-12766-8_9
MicroRNA-mediated regulation of Cadm1 contributes to beta cell function and energy homeostasis
Rathjen, T. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6345
Circulating Nucleic Acids and Diabetes Mellitus
Butt, A., & Swaminathan, R. (2014) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-017-9168-7_9
MicroRNAs: emerging regulators for development of pancreatic islet lineages
Jiang, F., & Morahan, G. (2013) · Non-coding RNAs in Endocrinology · doi:10.2478/micrnado-2013-0002
MicroRNA Research Reagent Review
Johnson, M. (2012) · Materials and Methods · doi:10.13070/mm.en.2.129
Sood, S. K., & Puri, S. (2011) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v4i5.65526
In Vivo Biomarkers for Detection of β Cell Death
Hinke, S. A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_35
“These microRNAs have been shown to play a role in endocrine pancreas development, α and β cell mass, insulin production, and glucose-stimulated insulin release (El Ouaamari et al. 2008; Fernandez-Valverde et al. 2011; Kredo-Russo et al. 2012; Melkman-Zehavi et al. 2011; Poy et al. 2009).”
Physiological effects of Type 2 diabetes on mRNA processing and gene expression
Morrison, F. S., Johnstone, K. A., & Harries, L. W. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.76
Regulation of Autoimmunity and Inflammation by microRNAs and Environmental Factors
Tormo-Badia, N. (2014) · Lund University Publications (Lund University)
Characterization of maternal plasma miRNAs expression profile by SOLiD sequencing
Li, H., Lu, Z., Ge, Q., Wu, Q., Guo, L., & Lu, J. (2011) · International Conference on Human Health and Biomedical Engineering · doi:10.1109/hhbe.2011.6028990
Epigenetics: An Intermediary of Environmental Regulation of
Pietrzykowski, Z. (2014) · Cited by 1
Dysregulation of MicroRNA Expression and Human Diseases?
Thai, T. (2012) · RNA technologies · doi:10.1007/978-3-642-27426-8_22
MicroRNA and Diabetes Mellitus
Salö, S., Geiger, J., Sørensen, A. E., & Dalgaard, L. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00021-x
Stanton, A. R. (2015) · California State University ScholarWorks (system-wide DSpace)
Post-transcriptional Regulation of Insulin and Insulin Like Growth Factors
Lee, E. K., & Kim, W. (2015) · Springer eBooks · doi:10.1007/978-3-319-25124-0_2
Next generation sequencing, an effective method for genomic profiling of circulating miRNA
Li, H., Lu, Z., Guo, L., Wu, Q., Ge, Q., & Lu, J. (2011) · Journal of Convergence Information Technology · doi:10.4156/jcit.vol6.issue12.55
Characterization of a MicroRNA Harboring Intron for Pre-mRNA Splicing and MicroRNA Processing
Aggarwal, N. (2010) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Regulation of adipogenesis and inflammation: role(s) of adipose microRNAs
Al-Jabir, M. J. M. H. (2016) · UCL Discovery (University College London)
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.